1. Home
  2. MLYS vs BWIN Comparison

MLYS vs BWIN Comparison

Compare MLYS & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$25.03

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo The Baldwin Insurance Group Inc.

BWIN

The Baldwin Insurance Group Inc.

HOLD

Current Price

$17.33

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
BWIN
Founded
2019
2011
Country
United States
United States
Employees
N/A
5020
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MLYS
BWIN
Price
$25.03
$17.33
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$48.67
$30.43
AVG Volume (30 Days)
1.9M
1.4M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
37.43
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$36.36
Revenue Next Year
N/A
$10.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.59
$15.88
52 Week High
$47.65
$43.25

Technical Indicators

Market Signals
Indicator
MLYS
BWIN
Relative Strength Index (RSI) 44.59 34.49
Support Level $22.36 $15.88
Resistance Level $31.29 $23.24
Average True Range (ATR) 1.43 1.00
MACD -0.22 -0.08
Stochastic Oscillator 28.15 5.91

Price Performance

Historical Comparison
MLYS
BWIN

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About BWIN The Baldwin Insurance Group Inc.

The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.

Share on Social Networks: